Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Prinomastat> ?p ?o. }
Showing items 1 to 40 of
40
with 100 items per page.
- Prinomastat abstract "Prinomastat (AG-3340) is a matrix metalloprotease (MMP) inhibitor with specific selectivity for MMPs 2, 3, 9, 13, and 14. Investigations have been carried out to determine whether the inhibition of these MMPs is able to block tumour metastasis by preventing MMP degradation of the extracellular matrix proteins and angiogenesis. Prinomastat underwent a Phase III trial to investigate its effectiveness against non-small cell lung cancer (nsclc), in combination with gemcitabine chemotherapy. However, it was discovered that Prinomastat did not improve the outcome of chemotherapy in advanced Non-Small-Cell Lung Cancer.".
- Prinomastat fdaUniiCode "10T6626FRK".
- Prinomastat pubchem "466151".
- Prinomastat thumbnail Prinomastat2DACS2.svg?width=300.
- Prinomastat wikiPageID "31997941".
- Prinomastat wikiPageRevisionID "603690458".
- Prinomastat c "18".
- Prinomastat chembl "75094".
- Prinomastat chemspiderid "409762".
- Prinomastat eliminationHalfLife "-18000.0".
- Prinomastat h "21".
- Prinomastat hasPhotoCollection Prinomastat.
- Prinomastat molecularWeight "423.5".
- Prinomastat n "3".
- Prinomastat o "5".
- Prinomastat pubchem "466151".
- Prinomastat s "2".
- Prinomastat unii "10".
- Prinomastat subject Category:Experimental_cancer_drugs.
- Prinomastat type Agent114778436.
- Prinomastat type Antineoplastic102722458.
- Prinomastat type CausalAgent100007347.
- Prinomastat type CytotoxicDrug103157987.
- Prinomastat type Drug103247620.
- Prinomastat type ExperimentalCancerDrugs.
- Prinomastat type Matter100020827.
- Prinomastat type Medicine103740161.
- Prinomastat type PhysicalEntity100001930.
- Prinomastat type Substance100020090.
- Prinomastat type Drug.
- Prinomastat type FunctionalSubstance.
- Prinomastat comment "Prinomastat (AG-3340) is a matrix metalloprotease (MMP) inhibitor with specific selectivity for MMPs 2, 3, 9, 13, and 14. Investigations have been carried out to determine whether the inhibition of these MMPs is able to block tumour metastasis by preventing MMP degradation of the extracellular matrix proteins and angiogenesis. Prinomastat underwent a Phase III trial to investigate its effectiveness against non-small cell lung cancer (nsclc), in combination with gemcitabine chemotherapy.".
- Prinomastat label "Prinomastat".
- Prinomastat sameAs m.0gvrkdq.
- Prinomastat sameAs Q7245228.
- Prinomastat sameAs Q7245228.
- Prinomastat sameAs Prinomastat.
- Prinomastat wasDerivedFrom Prinomastat?oldid=603690458.
- Prinomastat depiction Prinomastat2DACS2.svg.
- Prinomastat isPrimaryTopicOf Prinomastat.
